Publications

Journal Article Review Epublish 2 citations

PubMed: 40322371 DOI: 10.7759/cureus.81712

Association Between the Serum Uric Acid to Albumin Ratio and the No-Reflow Phenomenon After Percutaneous Coronary Intervention (PCI): A Systematic Review and Meta-Analysis.

Cureus 17(4):e81712

Authors: Mustafa B Ozbay, Serhat Degirmen, Aysenur Gullu, Bede N Nriagu, Mohammed Omer, Yasin Özen, Cagri Yayla

Affiliations

  • Internal Medicine, Penn Medicine Princeton Medical Center, Plainsboro, USA.
  • Internal Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA.
  • Internal Medicine, North Alabama Medical Center, Florence, USA.
  • Internal Medicine, Hurley Medical Center, Flint, USA.
  • Cardiology, Faculty of Medicine, Selcuk University, Konya, TUR.
  • Cardiology, Ankara City Hospital, University of Health Sciences, Ankara, TUR.

Abstract

The no-reflow phenomenon (NR) following percutaneous coronary intervention (PCI) is an unpredictable complication linked to increased in-hospital mortality and adverse cardiovascular outcomes. Reliable predictors of NR remain unclear. This systematic review and meta-analysis aimed to evaluate the association between serum uric acid to albumin ratio (UAR) and NR development after PCI. A comprehensive search of MEDLINE, Cochrane, and EMBASE databases identified observational studies assessing this relationship. Studies that provided multivariate regression analyses to determine whether UAR is an independent predictor of NR were included, and pooled odds ratios (OR) were calculated using random effects models. Three studies with a total of 2,199 patients were included. The pooled analysis demonstrated a significant association between higher UAR and an increased risk of NR (OR: 3.04; 95% CI: 2.26-4.10; p < 0.00001; I² = 0%). These findings indicate that a higher serum UAR is independently associated with NR development and may serve as a useful, easily measurable predictor in clinical practice.

MeSH

Uric Acid, Serum, Percutaneous Coronary Intervention, Hospital Mortality, No-Reflow Phenomenon